(Q46765203)

25 December 2017

title

In vitro susceptibility of oral Candida to seven antifungal agents (English)

1 reference

25 December 2017

author

David W Williams

2

1 reference

25 December 2017

author name string

Kuriyama T

1

1 reference

25 December 2017

Bagg J

3

1 reference

25 December 2017

Coulter WA

4

1 reference

25 December 2017

Ready D

5

1 reference

25 December 2017

Lewis MA

6

1 reference

25 December 2017

publication date

1 December 2005

1 reference

25 December 2017

Oral Microbiology and Immunology

published in

1 reference

25 December 2017

volume

20

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

349-353

1 reference

25 December 2017

Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailin

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-302X.2005.00236.X

Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-302X.2005.00236.X

Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? The National Institute of Allergy and Infectious Diseases Mycoses stu

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-302X.2005.00236.X

Yeast species and biotypes associated with oral leukoplakia and lichen planus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-302X.2005.00236.X

Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-302X.2005.00236.X

In vitro secreted aspartyl proteinase activity of Candida albicans isolated from oral diseases and healthy oral cavities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-302X.2005.00236.X

Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-302X.2005.00236.X

Frequency and clinical significance of bloodstream infections caused by C albicans strains with reduced susceptibility to fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-302X.2005.00236.X

Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-302X.2005.00236.X

Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-302X.2005.00236.X

In vitro susceptibility of Candida albicans isolates from apical and marginal periodontitis to common antifungal agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-302X.2005.00236.X

10.1111/J.1399-302X.2005.00236.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017